-
DEA-Licensed Cannabis Producer Bright Green Closes $3.5M Private Placement
Wednesday, May 24, 2023 - 6:42pm | 346Read More...Bright Green Corporation (NASDAQ: BGXX), one of the very few companies selected by the U.S. government and DEA to grow, manufacture and legally sell cannabis and cannabis-related products for research, announced the closing of its previously announced private placement of common...
-
DEA Says There Were More Cannabis Seizures In 2022 Though Fewer Arrests
Wednesday, May 24, 2023 - 9:57am | 854Read More...This article was initially published by the National Organization for the Reform of Marijuana Laws (NORML) and appears here with permission. Federal law enforcement agents and their partners seized nearly 5.7 million cultivated marijuana plants in 2022, according to annual data ...
-
US Justice Dept Charges El Chapo's Sons And Other Sinaloa Cartel Members In Fentanyl Trafficking
Sunday, April 16, 2023 - 3:24pm | 545Read More...Over 25 members of the Sinaloa cartel, including the sons of notorious drug lord Joaquin “El Chapo” Guzman, were charged on Friday in a fentanyl-trafficking investigation by the U.S. Justice Department. Of the three Guzmán sons, Ovidio, Jesús and Iván,...
-
End Of Road For The Man Who Duped The DEA And Sinaloa Cartel: Genaro García Luna Convicted In Brooklyn Courtroom
Tuesday, February 21, 2023 - 10:30pm | 448Read More...Genaro García Luna, once Mexico's security minister with close ties to the DEA and US government, was found guilty of taking millions of dollars in bribes from Mexico's Sinaloa Cartel while supposedly working to break up Mexico’s violent drug gangs. García Luna,...
-
DEA: Drug Cartels Producing Fentanyl Greatest Drug Threat Ever To US, CNN Visits Secret DEA Testing Lab
Sunday, February 5, 2023 - 2:38pm | 787Read More...DEA special agent Jon DeLena recently told Congress that the drug crisis underway today is unlike anything he’s ever seen in his 27 years with the agency. He called two Mexican cartels the greatest drug threat the U.S. has ever faced. “The Sinaloa and Jalisco cartels...
-
The Man Who Played The DEA, El Chapo's Sinaloa Cartel & US Government On Trial In Brooklyn
Saturday, January 28, 2023 - 6:26pm | 583Read More...Former cartel bosses, drug traffickers and police officers took the stand this week in the trial of Genaro García Luna, Mexico’s former federal security minister and architect of the country’s war on drugs, which he carried out while publicly working with the DEA and...
-
How Did This Mexican Police Boss Dupe The DEA And Become A Millionaire? Find Out Soon As His Trial Begins
Monday, January 16, 2023 - 2:06pm | 577Read More...It’s been nearly three years since Joaquín ‘El Chapo’ Guzmán was convicted and sentenced to life in prison plus 30 years. Now a former security minister is accused of being El Chapo’s man inside the Mexican government and is facing trial in the...
-
Donald Trump And Viktor Bout Seem To Have A Few Things In Common Despite The Former Pres' Protests
Monday, December 12, 2022 - 8:36pm | 863Read More...An abundance of individuals and groups are still agitated over every aspect of the Brittney Griner-Viktor Bout prisoner exchange. One DEA agent who oversaw the administration's past investigation of Viktor Bout told ABC News that the exchange was "really upsetting...
-
BREAKING: Cybin And Clinilabs Receive DEA License For First-In-Human Clinical Trial Of Psilocybin To Treat Depression
Wednesday, August 17, 2022 - 8:00am | 714Read More...Cybin Inc. (NEO: CYBN) (NYSE: CYBN) and Clinilabs Drug Development Corporation (Clinilabs) announced that the U.S. Drug Enforcement Agency (DEA) has granted a Schedule I license to support the first-in-human Phase 1/2a clinical trial of CYB003, a proprietary deuterated psilocybin analog being...
-
Activists Protest At DEA HQ, Demand Legal Access To Psychedelics For Terminally Ill Patients
Monday, May 9, 2022 - 6:11pm | 320Read More...Activists held a protest, including a die-in outside of the Drug Enforcement Administration (DEA) headquarters in Virginia. They were protesting against the DEA's “obstruction of Right to Try statutes at the federal and state level that patients and advocates say should...
-
DEA Under Fire For Blocking Psilocybin As Treatment For Terminally Ill Cancer Patients
Thursday, April 14, 2022 - 2:38pm | 646Read More...The Drug Enforcement Administration (DEA) will face activists at its headquarters in Arlington, Virginia, reported Mary-Elizabeth Gifford and Justin Grant of Lucid News. Protestors intend to block the entrance to the building to call attention to the rights of terminally ill...
-
DEA Raises Production Quota For Psychedelics Like MDMA, Psilocybin and DMT As Research Flourishes
Thursday, December 2, 2021 - 12:28pm | 287Read More...The Drug Enforcement Administration (DEA), has increased its quota for the legal production of psychedelic drugs such as psilocybin (also known as magic mushrooms), MDMA and DMT for 2022. This move by the DEA comes amid an increase of demand and interest within the scientific community...
-
Emerald Bioscience Creates Unique Path to Prevent Blindness Using Patented Synthetic Cannabinoids
Friday, December 4, 2020 - 11:17pm | 1198Read More...The following post was written and/or published as a collaboration between Benzinga’s in-house sponsored content team and a financial partner of Benzinga. The rapid innovation and growth in biotechnology is being used to define, validate, and enhance therapeutic outcomes from cannabinoids....
-
DEA Targets Nation's Meth 'Transportation Hubs'
Friday, February 21, 2020 - 9:48am | 346Read More...The U.S. Justice Department announced that the Drug Enforcement Administration (DEA) will dedicate resources to target "transportation hubs" throughout the country which are known hotspots for trafficking in methamphetamine. DEA named eight meth transportation hubs, which its officers will be...
-
Morgan Stanley: DEA Likely To Reclassify GW Pharma's Cannabinoid Therapy For US Launch
Wednesday, September 19, 2018 - 9:16am | 376Read More...By Sunday night, the U.S. Drug Enforcement Administration is expected to reclassify GW Pharmaceuticals PLC- ADR (NASDAQ: GWPH)’s Epidiolex to allow medicinal use. This could open the therapy to a new and promising market. The Analyst Morgan Stanley analyst David Lebowitz ...
















